{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:09:32Z","timestamp":1767704972284,"version":"3.48.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05352-y","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T15:31:24Z","timestamp":1764257484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short-course radiotherapy with or without temozolomide in elderly patients with newly diagnosed glioblastoma: a time-to-event meta-analysis of overall and progression-free survival"],"prefix":"10.1007","volume":"176","author":[{"given":"Kwadwo","family":"Darko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette E.","family":"Eckel-Passow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekokobe","family":"Fonkem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold B.","family":"Etame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"6","key":"5352_CR1","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/cam4.1070","volume":"6","author":"KS Mak","year":"2017","unstructured":"Mak KS, Agarwal A, Qureshi MM, Truong MT (2017) Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National cancer database. Cancer Med Jun 6(6):1192\u20131200. https:\/\/doi.org\/10.1002\/cam4.1070","journal-title":"Cancer Med Jun"},{"issue":"9","key":"5352_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/jco.2004.06.082","volume":"1","author":"W Roa","year":"2004","unstructured":"Roa W, Brasher PM, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol May 1(9):1583\u20131588. https:\/\/doi.org\/10.1200\/jco.2004.06.082","journal-title":"J Clin Oncol May"},{"issue":"1","key":"5352_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11060-020-03468-x","volume":"148","author":"CW Wee","year":"2020","unstructured":"Wee CW, Kim IH, Park CK et al (2020) Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort: is short-course radiotherapy enough or is it a matter of selection? J Neurooncol May 148(1):57\u201365. https:\/\/doi.org\/10.1007\/s11060-020-03468-x","journal-title":"J Neurooncol May"},{"issue":"11","key":"5352_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"16","author":"JR Perry","year":"2017","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ et al (2017) Short-Course radiation plus Temozolomide in elderly patients with glioblastoma. N Engl J Med Mar 16(11):1027\u20131037. https:\/\/doi.org\/10.1056\/NEJMoa1611977","journal-title":"N Engl J Med Mar"},{"issue":"4","key":"5352_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ijrobp.2017.03.037","volume":"15","author":"D Guedes de Castro","year":"2017","unstructured":"Guedes de Castro D, Matiello J, Roa W et al (2017) Survival outcomes with Short-Course radiation therapy in elderly patients with glioblastoma: data from a randomized phase 3 trial. Int J Radiat Oncol Biol Phys Jul 15(4):931\u2013938. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.037","journal-title":"Int J Radiat Oncol Biol Phys Jul"},{"key":"5352_CR6","doi-asserted-by":"publisher","unstructured":"Minniti G, Lombardi G, Paolini S (2019) Glioblastoma in elderly patients: current management and future perspectives. Cancers (Basel) Mar 8(3). https:\/\/doi.org\/10.3390\/cancers11030336","DOI":"10.3390\/cancers11030336"},{"issue":"4","key":"5352_CR7","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.3390\/curroncol28040220","volume":"26","author":"T Mir","year":"2021","unstructured":"Mir T, Pond G, Greenspoon JN (2021) Outcomes in elderly patients with glioblastoma multiforme treated with Short-Course radiation alone compared to Short-Course radiation and concurrent and adjuvant Temozolomide based on performance status and extent of resection. Curr Oncol Jun 26(4):2399\u20132408. https:\/\/doi.org\/10.3390\/curroncol28040220","journal-title":"Curr Oncol Jun"},{"issue":"3","key":"5352_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1447-0594.2006.00341.x","volume":"6","author":"H Orimo","year":"2006","unstructured":"Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M (2006) Reviewing the definition of elderly. Geriatr Gerontol Int 6(3):149\u2013158. https:\/\/doi.org\/10.1111\/j.1447-0594.2006.00341.x","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"5352_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/030089161009600110","volume":"96","author":"R Muni","year":"2010","unstructured":"Muni R, Minniti G, Lanzetta G et al (2010) Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma. Tumori Jan-Feb 96(1):60\u201364. https:\/\/doi.org\/10.1177\/030089161009600110","journal-title":"Tumori Jan-Feb"},{"issue":"7","key":"5352_CR10","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.31557\/apjcp.2022.23.7.2317","volume":"1","author":"S Thakur","year":"2022","unstructured":"Thakur S, Kumar N, Salunke P, Ahuja C, Madan R (2022) A randomized study of short course (One Week) radiation therapy with or without Temozolomide in elderly and\/or frail patients with newly diagnosed glioblastoma (GBM). Asian Pac J Cancer Prev Jul 1(7):2317\u20132323. https:\/\/doi.org\/10.31557\/apjcp.2022.23.7.2317","journal-title":"Asian Pac J Cancer Prev Jul"},{"key":"5352_CR11","unstructured":"Covidence systematic review software Veritas Health Innovation. Melbourne, Australia. www.covidence.org"},{"issue":"2","key":"5352_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/0145445516673998","volume":"41","author":"D Drevon","year":"2017","unstructured":"Drevon D, Fursa SR, Malcolm AL (2017) Intercoder reliability and validity of webplotdigitizer in extracting graphed data. Behav Modif Mar 41(2):323\u2013339. https:\/\/doi.org\/10.1177\/0145445516673998","journal-title":"Behav Modif Mar"},{"key":"5352_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","volume":"1","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades AE, Ouwens MJ, Welton NJ (2012) Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol Feb 1:12:9. https:\/\/doi.org\/10.1186\/1471-2288-12-9","journal-title":"BMC Med Res Methodol Feb"},{"key":"5352_CR14","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Bmj Oct 12 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"Bmj Oct 12"},{"key":"5352_CR15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"3","key":"5352_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-024-04752-w","volume":"169","author":"PS Pichardo-Rojas","year":"2024","unstructured":"Pichardo-Rojas PS, Pichardo-Rojas D, Mar\u00edn-Casta\u00f1eda LA et al (2024) Prognostic value of surgical resection over biopsy in elderly patients with glioblastoma: a meta-analysis. J Neurooncol Sep 169(3):469\u2013487. https:\/\/doi.org\/10.1007\/s11060-024-04752-w","journal-title":"J Neurooncol Sep"},{"issue":"15","key":"5352_CR17","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa065901","volume":"12","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med Apr 12(15):1527\u20131535. https:\/\/doi.org\/10.1056\/NEJMoa065901","journal-title":"N Engl J Med"},{"issue":"1","key":"5352_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijrobp.2011.06.1992","volume":"1","author":"G Minniti","year":"2012","unstructured":"Minniti G, Lanzetta G, Scaringi C et al (2012) Phase II study of short-course radiotherapy plus concomitant and adjuvant Temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys May 1(1):93\u201399. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.06.1992","journal-title":"Int J Radiat Oncol Biol Phys May"},{"issue":"9","key":"5352_CR19","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/s1470-2045(12)70265-6","volume":"13","author":"A Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m A, Gr\u00f8nberg BH, Marosi C et al (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the nordic randomised, phase 3 trial. Lancet Oncol Sep 13(9):916\u2013926. https:\/\/doi.org\/10.1016\/s1470-2045(12)70265-6","journal-title":"Lancet Oncol Sep"},{"issue":"10","key":"5352_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason W, van den Bent M et al (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. New Engl J Med (NEJM) 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"New Engl J Med (NEJM)"},{"issue":"10","key":"5352_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"M Hegi","year":"2005","unstructured":"Hegi M, Diserens A-C, Gorlia T et al (2005) MGMT gene Silencing and benefit from Temozolomide in glioblastoma. New Engl J Med (NEJM) 352(10):997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"New Engl J Med (NEJM)"},{"issue":"7","key":"5352_CR22","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/s1470-2045(12)70164-x","volume":"13","author":"W Wick","year":"2012","unstructured":"Wick W, Platten M, Meisner C et al (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant Astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol Jul 13(7):707\u2013715. https:\/\/doi.org\/10.1016\/s1470-2045(12)70164-x","journal-title":"Lancet Oncol Jul"},{"key":"5352_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.euros.2024.10.018","volume":"70","author":"EL Oh","year":"2024","unstructured":"Oh EL, Huish W, El-Gamil S, Benson T, Ferguson T (2024) Assessment of patient and clinician perspectives on clinically meaningful extension of Progression-free survival in prostate cancer. Eur Urol Open Sci Dec 70:175\u2013182. https:\/\/doi.org\/10.1016\/j.euros.2024.10.018","journal-title":"Eur Urol Open Sci Dec"},{"issue":"3","key":"5352_CR24","doi-asserted-by":"publisher","first-page":"Cd013261","DOI":"10.1002\/14651858.CD013261.pub2","volume":"23","author":"C Hanna","year":"2020","unstructured":"Hanna C, Lawrie TA, Rogozi\u0144ska E et al (2020) Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Cochrane Database Syst Rev Mar 23(3):Cd013261. https:\/\/doi.org\/10.1002\/14651858.CD013261.pub2","journal-title":"Cochrane Database Syst Rev Mar"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05352-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05352-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05352-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:34:59Z","timestamp":1767702899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05352-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5352"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05352-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was written in compliance with our institutional ethical review board. IRB approval was not required given the nature of the data collected and information presented.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB compliance statement and ethical adherence"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}